https://ibs.inc/2022/08/15/gbs-inc-announces-key-milestone-in-prospective-study-comparing-glucose-in-oral-fluids-and-blood/ 2026-06-11T03:51:08+00:00 https://ibs.inc/wp-content/uploads/2022/08/blue-dye.jpg https://ibs.inc/2022/06/28/gbs-inc-to-initiate-manufacturing-on-the-university-of-newcastle-australia-campus/ 2026-06-11T03:51:08+00:00 https://ibs.inc/wp-content/uploads/2022/08/microscope-close-up.jpg https://ibs.inc/2022/06/16/gbs-announcement-of-agreement-for-acquisition/ 2026-06-11T03:51:24+00:00 https://ibs.inc/wp-content/uploads/2022/06/Opioids.png https://ibs.inc/2022/03/31/gbs-inc-announces-institutional-review-board-approval-to-initiate-clinical-trial-at-sutter-health-mills-peninsula-medical-center/ 2026-06-11T03:51:25+00:00 https://ibs.inc/wp-content/uploads/2022/03/blue-saliva-microscopic.jpg https://ibs.inc/2021/07/26/gbs-inc-engages-l-e-k-consulting-hong-kong-pty-limited-to-identify-potential-sublicensees-in-china-for-its-saliva-glucose-diabetes-test/ 2026-06-11T03:51:26+00:00 https://ibs.inc/wp-content/uploads/2021/07/Asia.jpg https://ibs.inc/2021/11/30/gbs-inc-announces-plans-for-clinical-sars-cov-2-antibody-trials-following-validation-study/ 2026-06-11T03:51:26+00:00 https://ibs.inc/wp-content/uploads/2021/11/sars-cov-2-blue-covid-19-virus-particle.jpg https://ibs.inc/2021/07/08/gbs-awarded-4-7-million-australian-federal-government-science-grant-to-manufacture-biosensor-technology/ 2026-06-11T03:51:27+00:00 https://ibs.inc/wp-content/uploads/2023/04/test-tube.png https://ibs.inc/2021/04/15/gbs-inc-receives-approval-to-commence-validation-clinical-study-for-rapid-sars-cov-2-diagnostic-test/ 2026-06-11T03:51:28+00:00 https://ibs.inc/wp-content/uploads/2022/06/COVID-19.png https://ibs.inc/2021/06/08/patients-living-with-diabetes-voice-eagerness-for-finger-prick-alternative-in-global-glucose-monitoring-survey/ 2026-06-11T03:51:28+00:00 https://ibs.inc/wp-content/uploads/2022/06/Finger-Prick.png https://ibs.inc/2021/02/18/gbs-inc-enters-sponsored-research-agreement-with-johns-hopkins-bloomberg-school-of-public-health-to-accelerate-development-of-saliva-based-diagnostic-tests/ 2026-06-11T03:51:29+00:00 https://ibs.inc/wp-content/uploads/2021/02/Saliva.png https://ibs.inc/2026/06/16/inbs-initiates-clinical-study-supporting-fda-clearance/ 2026-06-16T12:30:33+00:00 https://ibs.inc/wp-content/uploads/2026/06/INBS-Initiates-Clinical-Study-Supporting-FDA-Clearance.png https://ibs.inc/2026/06/04/planet-microcap/ 2026-06-15T23:35:07+00:00 https://ibs.inc/wp-content/uploads/2026/06/Planet-MicroCap-Logo-Feature-Image.png https://ibs.inc/2026/05/13/inbs-reports-fiscal-third-quarter-revenue-growth-of-46-year-over-year/ 2026-06-15T23:35:08+00:00 https://ibs.inc/wp-content/uploads/2026/05/Intelligent-Bio-Solutions-Reports-Fiscal-Third-Quarter-Revenue-Growth-of-46-Year-over-Year.png https://ibs.inc/wp-content/uploads/2026/05/Fiscal-Q3-Earnings-PR-Condensed-Consolidated-Balance-Sheet-1-scaled.jpg https://ibs.inc/wp-content/uploads/2026/05/Fiscal-Q3-Earnings-PR-Condensed-Consolidated-Statements-of-Operations-scaled.jpg https://ibs.inc/2026/06/02/inbs-commences-method-comparison-study-for-fda-submission/ 2026-06-15T23:35:08+00:00 https://ibs.inc/wp-content/uploads/2026/05/INBS-Commences-Multi-Site-Method-Comparison-Study-for-FDA-510k-Submission.png https://ibs.inc/2026/04/20/inbs-rapid-drug-screening-targeting-70-faster-results/ 2026-06-15T23:35:09+00:00 https://ibs.inc/wp-content/uploads/2026/04/INBS-Initiates-Validation-Study-for-Rapid-Drug-Screening-Cartridge-Targeting-70-Faster-Results.png https://ibs.inc/2026/04/02/inbs-completes-clinical-cut-off-study/ 2026-06-15T23:35:10+00:00 https://ibs.inc/wp-content/uploads/2026/04/Intelligent-Bio-Solutions-Completes-Clinical-Cut-off-Study-Advances-FDA-510k-Clinical-Program-Targeting-Multi-Billion-Dollar-U.S.-Drug-Screening-Market.jpg https://ibs.inc/2026/04/17/inbs-successfully-completes-penetration-testing/ 2026-06-15T23:35:10+00:00 https://ibs.inc/wp-content/uploads/2026/04/Advances-Upcoming-FDA-510k-Submission-Successfully-Completes-Penetration-Testing-with-No-Major-Vulnerabilities-Identified.png https://ibs.inc/2026/03/26/inbs-strengthens-european-ip-portfolio-with-eighth-patent-grant/ 2026-06-15T23:35:11+00:00 https://ibs.inc/wp-content/uploads/2026/03/C1079_008e.jpg https://ibs.inc/2026/02/25/inbs-successfully-manufactures-first-readers-with-new-partner/ 2026-06-15T23:35:12+00:00 https://ibs.inc/wp-content/uploads/2026/02/INBS-Successfully-Manufactures-First-Readers-with-New-Partner-2.png https://ibs.inc/2026/02/12/inbs-reports-record-fiscal-second-quarter-revenue-growth/ 2026-06-15T23:35:13+00:00 https://ibs.inc/wp-content/uploads/2026/02/INBS-Reports-Record-Fiscal-Second-Quarter-Revenue-Growth.png https://ibs.inc/wp-content/uploads/2026/02/INBS-Reports-Record-Fiscal-Second-Quarter-Revenue-Growth-Table-1-scaled.png https://ibs.inc/wp-content/uploads/2026/02/INBS-Reports-Record-Fiscal-Second-Quarter-Revenue-Growth-Table-2-scaled.png https://ibs.inc/2026/02/24/inbs-partners-with-bouygues-uk-for-drug-testing-rollout/ 2026-06-15T23:35:13+00:00 https://ibs.inc/wp-content/uploads/2026/02/Intelligent-Bio-Solutions-Partners-with-Bouygues-UK.png https://ibs.inc/2026/02/05/inbs-expects-to-report-fiscal-q2-2026-revenue-growth-of-48/ 2026-06-15T23:35:14+00:00 https://ibs.inc/wp-content/uploads/2026/02/Intelligent-Bio-Solutions-Expects-to-Report-Fiscal-Second-Quarter-2026-Revenue-Growth-of-Approximately-48-Year-Over-Year-Surpassing-2-Million-in-Total-Revenue-for-First-Half-of-Fiscal-Year.png https://ibs.inc/2026/01/28/inbs-initiates-additional-clinical-studies-for-fda-510k-submission/ 2026-06-15T23:35:15+00:00 https://ibs.inc/wp-content/uploads/2026/01/Clinical-Studies-FDA-510k.png https://ibs.inc/2025/12/31/intelligent-bio-solutions-announces-new-manufacturing-partnership/ 2026-06-15T23:35:16+00:00 https://ibs.inc/wp-content/uploads/2025/12/manufacturing-partnership.png https://ibs.inc/2025/12/12/intelligent-bio-solutions-inc-announces-reverse-stock-split/ 2026-06-15T23:35:17+00:00 https://ibs.inc/wp-content/uploads/2025/12/Intelligent-Bio-Solutions-Inc.-Announces-Reverse-Stock-Split.png https://ibs.inc/2025/11/20/inbs-to-participate-in-noble-capital-markets-conference/ 2026-06-15T23:35:18+00:00 https://ibs.inc/wp-content/uploads/2025/11/IFP-Website-Article-Feature-Image-42.png https://ibs.inc/2025/11/04/inbs-expects-to-report-record-fiscal-q1-2026-revenue/ 2026-06-15T23:35:19+00:00 https://ibs.inc/wp-content/uploads/2025/10/INBS-Expects-to-Report-Record-Fiscal-Q1-2026-Revenue.png https://ibs.inc/2025/11/12/inbs-reports-fiscal-2026-q1-financial-results/ 2026-06-15T23:35:19+00:00 https://ibs.inc/wp-content/uploads/2025/11/IFP-Website-Article-Feature-Image-8.png https://ibs.inc/wp-content/uploads/2025/11/FINAL_Fiscal-Q1-2026-Earnings-PR-11.11.25_Page_4-edited-scaled.jpg https://ibs.inc/wp-content/uploads/2025/11/FINAL_Fiscal-Q1-2026-Earnings-PR-11.11.25_Page_5.jpg https://ibs.inc/wp-content/uploads/2025/11/FINAL_Fiscal-Q1-2026-Earnings-PR-11.11.25_Page_6.jpg https://ibs.inc/wp-content/uploads/2025/11/FINAL_Fiscal-Q1-2026-Earnings-PR-11.11.25_Page_7.jpg https://ibs.inc/2025/10/30/inbs-secures-33-new-customer-accounts-in-fiscal-q1-2026/ 2026-06-15T23:35:20+00:00 https://ibs.inc/wp-content/uploads/2025/10/INBS-Secures-33-New-Customer-Accounts-in-Fiscal-Q1-2026.png https://ibs.inc/2025/12/18/inbs-partners-with-non-invasive-screening-provider-vlepis/ 2026-06-15T23:36:26+00:00 https://ibs.inc/wp-content/uploads/2025/12/INBS-Partners-with-Non-Invasive-Screening-Provider-Vlepis.png https://ibs.inc/2025/10/23/inbs-secures-major-contract-with-industrial-service-provider/ 2026-06-15T23:37:02+00:00 https://ibs.inc/wp-content/uploads/2025/10/drug-testing-technology.png https://ibs.inc/2025/09/26/inbs-provides-updated-timeline-for-anticipated-fda-submission/ 2026-06-15T23:37:04+00:00 https://ibs.inc/wp-content/uploads/2025/09/INBS-Provides-Updated-Timeline-for-Anticipated-FDA-Submission.png https://ibs.inc/2025/10/06/webinar-introducing-fingerprint-drug-testing/ 2026-06-15T23:37:04+00:00 https://ibs.inc/wp-content/uploads/2025/10/Webinar-Introducing-Fingerprint-Drug-Testing.png https://ibs.inc/2025/09/17/inbs-provides-update-on-fda-510k-clearance-process/ 2026-06-15T23:37:05+00:00 https://ibs.inc/wp-content/uploads/2024/11/Intelligent-Fingerprinting-Drug-Test-21-1-scaled.jpg https://ibs.inc/2025/08/06/intelligent-bio-solutions-announces-preliminary-fiscal-fourth-quarter-revenue/ 2026-06-15T23:37:06+00:00 https://ibs.inc/wp-content/uploads/2025/08/Website-Article-Feature-Image-18.png https://ibs.inc/2025/08/15/inbs-reports-fiscal-2025-fourth-quarter-and-full-year-results/ 2026-06-15T23:37:06+00:00 https://ibs.inc/wp-content/uploads/2025/08/Website-Article-Feature-Image-19.png https://ibs.inc/wp-content/uploads/2025/08/FINAL_Earnings-PR-08.13.2025_Page_4-scaled.jpg https://ibs.inc/wp-content/uploads/2025/08/FINAL_Earnings-PR-08.13.2025_Page_5-scaled.jpg https://ibs.inc/2025/08/06/intelligent-bio-solutions-strengthens-fda-510k-package-ahead-of-us-launch/ 2026-06-15T23:37:07+00:00 https://ibs.inc/wp-content/uploads/2025/08/Website-Article-Feature-Image-17.png https://ibs.inc/2025/07/23/inbs-to-strengthen-fda-submission-with-new-positive-data/ 2026-06-15T23:37:08+00:00 https://ibs.inc/wp-content/uploads/2025/07/Intelligent-Bio-Solutions-INBS-to-Strengthen-FDA-510k-Submission-with-New-Data-Demonstrating-Ultra-Precise-Fingerprint-Sweat-Detection.png https://ibs.inc/2025/07/30/intelligent-bio-solutions-wins-major-drug-testing-tender/ 2026-06-15T23:37:08+00:00 https://ibs.inc/wp-content/uploads/2025/07/Intelligent-Bio-Solutions-Secures-Major-Drug-Testing-Tender.png https://ibs.inc/2025/07/16/inbs-smartest-patch-global-distribution-agreement/ 2026-06-15T23:37:09+00:00 https://ibs.inc/wp-content/uploads/2025/07/INBS-SmarTest%C2%AE-Patch-Global-Distribution-Agreement.png https://ibs.inc/2025/07/15/inbs-adds-smartest-sweat-drug-test-patch-to-product-portfolio/ 2026-06-15T23:37:10+00:00 https://ibs.inc/wp-content/uploads/2025/07/SmarTest-Sweat-Drug-Test-Patch.png https://ibs.inc/2025/07/10/inbs-to-present-pk-study-data-at-adlm-2025-clinical-lab-expo/ 2026-06-15T23:37:11+00:00 https://ibs.inc/wp-content/uploads/2025/07/INBS-to-Present-Fingerprint-Drug-Test-PK-Study-Data-at-ADLM-2025-Clinical-Lab-Expo.png https://ibs.inc/2025/06/25/inbs-and-spjotgard-drive-rapid-adoption-of-fingerprint-drug-testing-across-scandinavia/ 2026-06-15T23:37:12+00:00 https://ibs.inc/wp-content/uploads/2025/06/Spjotgard-Driving-Fingerprint-Drug-Testing-Across-Scandinavia-.png https://ibs.inc/2025/06/11/inbs-expands-u-s-forensic-market-presence-with-smartox/ 2026-06-15T23:37:15+00:00 https://ibs.inc/wp-content/uploads/2025/06/INBS-Expands-U.S.-Forensic-Market-Presence-with-SMARTOX.png https://ibs.inc/2025/10/07/fingerprint-drug-testing-at-the-whs-show-sydney/ 2026-06-15T23:37:31+00:00 https://ibs.inc/wp-content/uploads/2025/10/IFP-Website-Article-Feature-Image.png https://ibs.inc/2025/06/25/drug-test-detection-times/ 2026-06-15T23:37:51+00:00 https://ibs.inc/wp-content/uploads/2025/05/drug-test-detection-times.png https://ibs.inc/2025/06/18/sweat-drug-test/ 2026-06-15T23:38:05+00:00 https://ibs.inc/wp-content/uploads/2025/05/sweat-drug-test.png https://ibs.inc/2025/06/18/inbs-fingerprint-drug-testing-for-managed-waste-service/ 2026-06-15T23:38:11+00:00 https://ibs.inc/wp-content/uploads/2025/06/INBS-Fingerprint-Drug-Testing-for-Managed-Waste-Service.png https://ibs.inc/2025/06/11/cost-effective-drug-testing/ 2026-06-15T23:38:18+00:00 https://ibs.inc/wp-content/uploads/2025/05/cost-effective-drug-testing.png https://ibs.inc/2025/06/04/drug-testing-at-work/ 2026-06-15T23:38:30+00:00 https://ibs.inc/wp-content/uploads/2025/05/drug-testing-at-work.png https://ibs.inc/2025/05/22/inbs-to-showcase-fingerprint-drug-testing-at-rise25-conference/ 2026-06-15T23:38:53+00:00 https://ibs.inc/wp-content/uploads/2025/05/RISE25-Conference-Logo-1.png https://ibs.inc/2025/05/19/inbs-showcases-rapid-non-invasive-drug-testing-in-remote-australia/ 2026-06-15T23:38:53+00:00 https://ibs.inc/wp-content/uploads/2025/05/INBS-Showcases-Rapid-Non-Invasive-Drug-Testing-in-Remote-Australia.png https://ibs.inc/2025/05/14/inbs-accelerates-global-adoption-of-fingerprint-drug-testing/ 2026-06-15T23:38:55+00:00 https://ibs.inc/wp-content/uploads/2025/05/INBS-Accelerates-Global-Adoption-of-Fingerprint-Drug-Testing.png https://ibs.inc/2025/05/13/inbs-q3-2025-financial-results-and-key-achievements/ 2026-06-15T23:38:56+00:00 https://ibs.inc/wp-content/uploads/2025/05/INBS-Q3-2025-Financial-Results-and-Key-Achievements.png https://ibs.inc/wp-content/uploads/2025/05/Q3-2025-INBS-Financial-Table-1.png https://ibs.inc/wp-content/uploads/2025/05/Q3-2025-INBS-Financial-Table-2.png https://ibs.inc/2025/05/06/inbs-drives-global-growth-through-multilingual-digital-expansion/ 2026-06-15T23:38:57+00:00 https://ibs.inc/wp-content/uploads/2025/05/INBS-Drives-Global-Growth-Through-Multilingual-Digital-Expansion.png https://ibs.inc/2025/03/26/inbs-6th-us-patent/ 2026-06-15T23:39:02+00:00 https://ibs.inc/wp-content/uploads/2025/03/US-Patent.png https://ibs.inc/2025/03/25/inbs-fda-clearance-process-remains-on-track-for-2025-us-launch/ 2026-06-15T23:39:03+00:00 https://ibs.inc/wp-content/uploads/2025/03/INBS-FDA-Clearance-Process-Remains-on-Track-for-U.S.-Launch.png https://ibs.inc/2025/03/20/inbs-to-expand-u-s-ip-portfolio-with-expected-patent-grant/ 2026-06-15T23:39:04+00:00 https://ibs.inc/wp-content/uploads/2025/03/INBS-to-Expand-U.S.-IP-Portfolio-with-Expected-Patent-Grant.png https://ibs.inc/2025/02/13/inbs-announces-fiscal-2025-second-quarter-financial-results/ 2026-06-15T23:39:05+00:00 https://ibs.inc/wp-content/uploads/2025/02/INBS-Announces-Fiscal%E2%80%AF2025%E2%80%AFSecond-Quarter%E2%80%AFFinancial%E2%80%AFResults.png https://ibs.inc/2025/05/28/random-drug-testing-at-work-a-simpler-way-to-stay-compliant/ 2026-06-15T23:39:12+00:00 https://ibs.inc/wp-content/uploads/2025/05/Random-Drug-Testing-at-Work.png https://ibs.inc/2025/05/15/how-far-back-does-fingerprint-drug-testing-go/ 2026-06-15T23:39:21+00:00 https://ibs.inc/wp-content/uploads/2025/05/How-Far-Back-Does-Fingerprint-Drug-Testing-Go.png https://ibs.inc/2025/05/07/workplace-drug-testing-legal-and-ethical-considerations/ 2026-06-15T23:39:26+00:00 https://ibs.inc/wp-content/uploads/2025/05/Workplace-Drug-Testing-Legal-and-Ethical-Considerations.png https://ibs.inc/2025/04/30/the-real-cost-of-workplace-drug-testing/ 2026-06-15T23:39:34+00:00 https://ibs.inc/wp-content/uploads/2025/05/drug-and-alcohol-misuse.png https://ibs.inc/2025/04/22/inbs-expands-global-reach-with-latin-american-spanish-reader-upgrade/ 2026-06-15T23:39:41+00:00 https://ibs.inc/wp-content/uploads/2025/04/Latin-American-Spanish.png https://ibs.inc/2025/04/15/the-history-of-fingerprint-drug-testing/ 2026-06-15T23:39:50+00:00 https://ibs.inc/wp-content/uploads/2025/04/Fingerprint-Drug-Testing.webp https://ibs.inc/2025/04/05/fingerprint-drug-testing-demo/ 2026-06-15T23:39:54+00:00 https://ibs.inc/wp-content/uploads/2025/04/Fingerprint-Drug-Testing-Demo.webp https://ibs.inc/2025/03/31/inbs-expands-reach-with-arabic-drug-screening-system/ 2026-06-15T23:40:03+00:00 https://ibs.inc/wp-content/uploads/2025/03/Arabic.png https://ibs.inc/wp-content/uploads/2025/03/INBS-Expands-Reach-with-Arabic-Drug-Screening-System-2.png https://ibs.inc/2025/03/27/inbs-continues-expansion-with-partnership-in-spain-and-andorra/ 2026-06-15T23:40:07+00:00 https://ibs.inc/wp-content/uploads/2025/03/INBS-Continues-Expansion-with-Partnership-in-Spain-and-Andorra.png https://ibs.inc/2025/03/23/how-does-fingerprint-drug-testing-compare-to-urine-and-saliva/ 2026-06-15T23:40:16+00:00 https://ibs.inc/wp-content/uploads/2025/03/How-Does-Fingerprint-Drug-Testing-Compare-to-Urine-and-Saliva.webp https://ibs.inc/2025/02/10/inbs-releases-shareholder-letter-detailing-growth-and-expansion/ 2026-06-15T23:40:32+00:00 https://ibs.inc/wp-content/uploads/2025/02/INBS-Releases-Shareholder-Letter-Detailing-Growth-and-Expansion.png https://ibs.inc/2025/02/07/inbs-expands-with-uk-partnership-driving-global-growth/ 2026-06-15T23:40:51+00:00 https://ibs.inc/wp-content/uploads/2025/02/INBS-Expands-with-UK-Partnership.png https://ibs.inc/2025/01/29/inbs-adds-quantum-tm-to-client-portfolio/ 2026-06-15T23:40:52+00:00 https://ibs.inc/wp-content/uploads/2025/01/IBS-Website-Article-Photo-3.png https://ibs.inc/2025/01/28/inbs-to-expand-in-europe-and-middle-east/ 2026-06-15T23:40:52+00:00 https://ibs.inc/wp-content/uploads/2025/01/INBS-to-Expand-in-Europe-and-Middle-East.png https://ibs.inc/2025/01/31/multilingual-intelligent-fingerprinting-drug-screening-system-upgrade/ 2026-06-15T23:40:52+00:00 https://ibs.inc/wp-content/uploads/2025/01/Multilingual-Drug-Screening.png https://ibs.inc/2025/02/06/inbs-fiscal-q2-2025-preliminary-unaudited-financial-results/ 2026-06-15T23:40:52+00:00 https://ibs.inc/wp-content/uploads/2025/02/INBS-Fiscal-Q2-2025.png https://ibs.inc/2025/01/14/inbs-partners-with-princebuild-to-transition-from-saliva-testing-to-fingerprint-drug-screening/ 2026-06-15T23:40:53+00:00 https://ibs.inc/wp-content/uploads/2025/01/IBS-Website-Article-Photo-1.png https://ibs.inc/2024/11/27/intelligent-bio-solutions-achieves-high-accuracy-in-method-comparison-study-following-positive-pk-study-results/ 2026-06-15T23:40:54+00:00 https://ibs.inc/wp-content/uploads/2024/11/IBS-Website-Article-Photo-for-Method-Comparison-Study-1.png https://ibs.inc/2024/12/18/inbs-announces-510k-submission-to-fda-for-fingerprint-based-drug-screening-technology/ 2026-06-15T23:40:54+00:00 https://ibs.inc/wp-content/uploads/2024/12/Intelligent-Fingerprinting-Drug-Test.png https://ibs.inc/2024/11/20/inbs-pk-study-results/ 2026-06-15T23:40:55+00:00 https://ibs.inc/wp-content/uploads/2024/11/INBS-PK-Study-Results.jpg https://ibs.inc/2024/11/07/inbs-reports-fiscal-2025-first-quarter-financial-results-and-operational-highlights/ 2026-06-15T23:40:56+00:00 https://ibs.inc/wp-content/uploads/2024/11/IBS-Website-Article-Photo.jpg https://ibs.inc/wp-content/uploads/2024/11/Balance-Sheets-e1730931275903.webp https://ibs.inc/wp-content/uploads/2024/11/Statement-of-Operations.webp https://ibs.inc/2024/10/29/inbs-announces-preliminary-fiscal-2025-first-quarter-revenue-results/ 2026-06-15T23:40:57+00:00 https://ibs.inc/wp-content/uploads/2024/10/IBS-Website-Article-Photo-2.jpg https://ibs.inc/2024/10/14/pyrotek-adopts-inbs-non-invasive-drug-test/ 2026-06-15T23:40:58+00:00 https://ibs.inc/wp-content/uploads/2024/10/Pyrotek-Adopts-INBS-Non-Invasive-Drug-Screening-Solution.webp https://ibs.inc/2024/10/24/mount-anvil-celebrates-1-year-of-drug-testing-with-inbs/ 2026-06-15T23:40:58+00:00 https://ibs.inc/wp-content/uploads/2024/10/INBS-Mount-Anvil-Drug-Testing.jpg https://ibs.inc/2024/10/09/inbs-partners-with-spirit-group-as-australian-distributor/ 2026-06-15T23:40:59+00:00 https://ibs.inc/wp-content/uploads/2024/10/INBS-partners-with-Spirit-Group-as-Australian-Distributor-.webp https://ibs.inc/2024/09/27/inbs-concludes-in-clinic-testing-for-clinical-study-plan/ 2026-06-15T23:41:00+00:00 https://ibs.inc/wp-content/uploads/2024/09/INBS-Concludes-In-Clinic-Testing-for-Clinical-Study-Plan.webp https://ibs.inc/2024/10/01/gps-marine-adopts-inbs-fingerprint-drug-test/ 2026-06-15T23:41:00+00:00 https://ibs.inc/wp-content/uploads/2024/09/GPS-Marine-Adopts-INBS-Fingerprint-Drug-Testing-Technology-.webp https://ibs.inc/2024/09/25/thanet-earth-adopts-inbs-fingerprint-drug-test/ 2026-06-15T23:41:01+00:00 https://ibs.inc/wp-content/uploads/2024/09/Thanet-Earth-Adopts-INBS-Fingerprint-Drug-Test-to-Enhance-Workplace-Safety.webp https://ibs.inc/2024/09/19/inbs-reports-fiscal-2024-q4-and-full-year-results/ 2026-06-15T23:41:02+00:00 https://ibs.inc/wp-content/uploads/2024/09/INBS-Reports-Fiscal-2024-Q4-and-Full-Year-Results-1.webp https://ibs.inc/wp-content/uploads/2024/09/INBS-Consolidated-Balance-Sheets-2024.png https://ibs.inc/wp-content/uploads/2024/09/INBS-Consolidated-Statements-of-Operations-and-Other-Comprehensive-Income.png https://ibs.inc/2024/11/14/inbs-announces-positive-results-of-pk-study-a-key-milestone-on-path-to-fda-510k-submission/ 2026-06-15T23:42:33+00:00 https://ibs.inc/wp-content/uploads/2024/11/IBS-Website-PK-Study-Results-Announcement.webp https://ibs.inc/wp-content/uploads/2024/11/INBS-Results-of-PK-Study-post-image.webp https://ibs.inc/2024/10/31/b2i-digital-to-raise-awareness-of-drug-screening-system/ 2026-06-15T23:42:55+00:00 https://ibs.inc/wp-content/uploads/2024/10/IBS-Website-Article-Photo-1.jpg https://ibs.inc/2024/09/09/inbs-announces-preliminary-2024-revenue-growth-of-148-yoy/ 2026-06-15T23:43:22+00:00 https://ibs.inc/wp-content/uploads/2024/09/INBS-Announces-Preliminary-2024-Revenue-Growth-of-148-YoY.webp https://ibs.inc/2024/09/05/inbs-makes-progress-toward-completion-of-clinical-study-plan/ 2026-06-15T23:43:23+00:00 https://ibs.inc/wp-content/uploads/2024/09/INBS-Method-Comparison.jpg https://ibs.inc/2024/08/21/inbs-installs-over-1000-drug-screening-readers/ 2026-06-15T23:43:25+00:00 https://ibs.inc/wp-content/uploads/2024/08/INBS-Installs-Over-1000-Drug-Screening-Readers-scaled.jpg https://ibs.inc/2024/08/13/inbs-highlights-growing-need-for-drug-testing-solutions/ 2026-06-15T23:43:26+00:00 https://ibs.inc/wp-content/uploads/2024/08/INBS-Highlights-Growing-Need-for-Drug-Testing-Solutions.png https://ibs.inc/2024/08/01/inbs-partners-with-cenexel-to-conduct-clinical-study/ 2026-06-15T23:43:27+00:00 https://ibs.inc/wp-content/uploads/2024/08/INBS-Partners-with-CenExel-to-Conduct-Clinical-Study.png https://ibs.inc/2024/07/24/inbs-announces-qabas-as-exclusive-distributor-in-saudi-arabia/ 2026-06-15T23:43:27+00:00 https://ibs.inc/wp-content/uploads/2024/07/INBS-Announces-Qabas-as-Exclusive-Distributor-in-Saudi-Arabia.png https://ibs.inc/2024/07/18/inbs-advances-fda-510k-pathway-with-biocompatibility-study/ 2026-06-15T23:43:28+00:00 https://ibs.inc/wp-content/uploads/2024/07/INBS-Advances-FDA-510k-Pathway-with-Biocompatibility-Study.png https://ibs.inc/2024/06/28/inbs-completes-in-clinic-portion-of-pk-study/ 2026-06-15T23:43:29+00:00 https://ibs.inc/wp-content/uploads/2024/06/INBS-Completes-In-Clinic-Portion-of-PK-Study.png https://ibs.inc/2024/07/09/inbs-strengthens-uk-market-position-with-manufacturing-accounts/ 2026-06-15T23:43:29+00:00 https://ibs.inc/wp-content/uploads/2024/07/INBS-Strengthens-UK-Market-Position-with-ADDITION-OF-KEY-MANUFACTURING-ACCOUNTS.png https://ibs.inc/2024/06/27/inbs-expands-presence-in-the-uk-retail-sector/ 2026-06-15T23:43:30+00:00 https://ibs.inc/wp-content/uploads/2024/06/INBS-Expands-Presence-in-the-UK-Retail-Sector.png https://ibs.inc/2024/06/20/inbs-secures-two-key-accounts-in-the-warehouse-and-logistics-sector/ 2026-06-15T23:43:31+00:00 https://ibs.inc/wp-content/uploads/2024/06/IBS-Article-Photo-June-20.png https://ibs.inc/2024/06/18/inbs-begins-subject-dosing-and-sampling-for-fda-510k-pk-study/ 2026-06-15T23:43:32+00:00 https://ibs.inc/wp-content/uploads/2024/06/IBS-Article-Photo-June-18.png https://ibs.inc/2024/05/28/inbs-completes-recruitment-for-fda-510k-pk-study/ 2026-06-15T23:43:34+00:00 https://ibs.inc/wp-content/uploads/2024/05/INBS-Completes-Recruitment-for-FDA-510k-PK-Study-1.png https://ibs.inc/2024/06/12/inbs-adds-major-eu-transport-infrastructure-solutions-provider/ 2026-06-15T23:43:34+00:00 https://ibs.inc/wp-content/uploads/2024/06/IBS-Article-Photo-10.png https://ibs.inc/2024/05/23/inbs-unveils-key-performance-indicator-growth-in-the-united-kingdom-as-drug-screening-industry-combats-drug-test-cheating-and-searches-for-simpler-faster-non-invasive-and-more-cost-effective-solutio/ 2026-06-15T23:43:35+00:00 https://ibs.inc/wp-content/uploads/2024/05/INBS-Unveils-Key-Performance-Indicator-Growth-in-the-UK.png https://ibs.inc/2024/05/08/inbs-reports-fiscal-q3-and-9-month-financial-results/ 2026-06-15T23:43:36+00:00 https://ibs.inc/wp-content/uploads/2024/05/INBS-Reports-Fiscal-Q3-and-9-Month-Financial-Results-1.png https://ibs.inc/wp-content/uploads/2024/05/INBS-Reports-Fiscal-Q3-and-9-Month-Financial-Results-p1.png https://ibs.inc/wp-content/uploads/2024/05/INBS-Reports-Fiscal-Q3-and-9-Month-Financial-Results-p2-edited-1.png https://ibs.inc/2024/05/17/fingerprint-drug-test-showcased-at-premier-health-safety-event/ 2026-06-15T23:43:36+00:00 https://ibs.inc/wp-content/uploads/2024/05/Fingerprint-Drug-Test-Showcased-at-Premier-Health-Safety-Event-.png https://ibs.inc/2024/09/02/fingerprint-drug-testing-the-key-to-safer-smarter-drug-screening-in-the-workplace/ 2026-06-15T23:43:53+00:00 https://ibs.inc/wp-content/uploads/2024/09/Fingerprint-Drug-Testing.png https://ibs.inc/wp-content/uploads/2024/09/image.jpeg https://ibs.inc/2024/09/03/inbs-reports-118-growth-in-customer-employee-base/ 2026-06-15T23:44:08+00:00 https://ibs.inc/wp-content/uploads/2024/09/INBS-Reports-118-Growth-in-Customer-Employee-Base.webp https://ibs.inc/2024/06/13/inbs-strategic-reorganization-to-support-global-growth/ 2026-06-15T23:44:30+00:00 https://ibs.inc/wp-content/uploads/2024/06/IBS-Article-Photo-11.png https://ibs.inc/2024/04/18/inbs-announces-preliminary-unaudited-fiscal-third-quarter-and-nine-month-revenue-results/ 2026-06-15T23:45:05+00:00 https://ibs.inc/wp-content/uploads/2024/04/INBS-Preliminary-Unaudited-Fiscal-Q3-Revenue-Results.png https://ibs.inc/2024/04/11/inbs-broadens-ip-portfolio-with-new-european-patent/ 2026-06-15T23:45:07+00:00 https://ibs.inc/wp-content/uploads/2024/04/IBS-Article-Photo.png https://ibs.inc/2024/02/16/inbs-regains-compliance-with-nasdaq-minimum-bid-price/ 2026-06-15T23:45:08+00:00 https://ibs.inc/wp-content/uploads/2024/02/INBS-Regains-Compliance-with-Nasdaq-Minimum-Bid-Price-.png https://ibs.inc/2024/02/29/intelligent-bio-solutions-partners-with-cliantha-research-to-conduct-clinical-study-as-part-of-fda-510k-pathway/ 2026-06-15T23:45:08+00:00 https://ibs.inc/wp-content/uploads/2024/02/INBS-to-Conduct-Clinical-Study-as-part-of-FDA-Pathway.png https://ibs.inc/2024/02/10/inbs-reports-fiscal-q2-and-6-month-financial-results/ 2026-06-15T23:45:09+00:00 https://ibs.inc/wp-content/uploads/2024/02/INBS-Reports-Fiscal-Q2-and-6-Month-Financial-Results.png https://ibs.inc/wp-content/uploads/2024/02/INBS-Finanvials-090224_Page_1-e1707348614921.png https://ibs.inc/wp-content/uploads/2024/02/INBS-Finanvials-090224_Page_2-e1707348552259.png https://ibs.inc/wp-content/uploads/2024/02/INBS-Finanvials-090224_Page_1-edited.png https://ibs.inc/wp-content/uploads/2024/02/INBS-Finanvials-090224_Page_4-e1707348360731.png https://ibs.inc/2024/02/03/inbs-announces-preliminary-unaudited-fiscal-second-quarter-and-six-month-revenue-results/ 2026-06-15T23:45:10+00:00 https://ibs.inc/wp-content/uploads/2024/02/IFP-Website-Article-Feature-Image-36.png https://ibs.inc/2024/01/30/james-jones-sons-adopts-intelligent-fingerprinting-drug-test/ 2026-06-15T23:45:11+00:00 https://ibs.inc/wp-content/uploads/2024/01/Leading-UK-Timber-Processor-and-Packaging-Manufacturer-James-Jones-Sons-Ltd.-Adopts-Intelligent-Bio-Solutions-Fingerprint-Drug-Screening-System-Across-its-25-Sites-and-1300-Employees.png https://ibs.inc/2024/01/31/fingerprint-drug-test-delivers-quantifiable-benefits-for-customers/ 2026-06-15T23:45:11+00:00 https://ibs.inc/wp-content/uploads/2024/01/Fingerprint-Drug-Test.png https://ibs.inc/2024/01/23/dgp-plc-takes-drug-testing-in-house-with-fingerprint-drug-test/ 2026-06-15T23:45:12+00:00 https://ibs.inc/wp-content/uploads/2024/01/DGP-Plc-Takes-Drug-Testing-In-house-with-Fingerprint-Sweat-based-Testing.png https://ibs.inc/2023/12/06/po-ferries-adopts-fingerprint-drug-screening-solution/ 2026-06-15T23:45:15+00:00 https://ibs.inc/wp-content/uploads/2023/12/IFP-Website-Article-Feature-Image.png https://ibs.inc/2023/12/01/titan-cranes-adopts-intelligent-fingerprinting-drug-screening/ 2026-06-15T23:45:16+00:00 https://ibs.inc/wp-content/uploads/2023/11/Titan-Cranes.png https://ibs.inc/2023/11/28/state-road-constructions-selects-fingerprinting-drug-screening/ 2026-06-15T23:45:18+00:00 https://ibs.inc/wp-content/uploads/2023/11/IBS-Article-Photo-1.png https://ibs.inc/2024/05/06/fingerprint-drug-tests-compared-to-urine-and-saliva/ 2026-06-15T23:45:26+00:00 https://ibs.inc/wp-content/uploads/2024/05/Comparing-Fingerprint-Drug-Tests-to-Urine-and-Saliva.png https://ibs.inc/2024/04/18/leveraging-fingerprint-testing-for-non-invasive-health-monitoring/ 2026-06-15T23:45:38+00:00 https://ibs.inc/wp-content/uploads/2024/04/IBS-Article-Photo-1.png https://ibs.inc/2024/01/19/robinson-brothers-adopts-intelligent-fingerprinting-drug-screening/ 2026-06-15T23:46:16+00:00 https://ibs.inc/wp-content/uploads/2024/01/Robinson-Brothers-Drug-Screening.png https://ibs.inc/2023/12/18/fingerprint-drug-test-receives-nata-accreditation/ 2026-06-15T23:47:09+00:00 https://ibs.inc/wp-content/uploads/2023/04/lab-test.png https://ibs.inc/2023/12/13/substance-abuse-crisis-among-white-collar-professionals/ 2026-06-15T23:47:20+00:00 https://ibs.inc/wp-content/uploads/2023/12/White-collar-substance-abuse.png https://ibs.inc/2023/11/30/intelligent-bio-solutions-inc-to-present-at-the-emerging-growth-conference-on-december-7-2023/ 2026-06-15T23:47:29+00:00 https://ibs.inc/wp-content/uploads/2023/11/Analytics.png https://ibs.inc/2023/11/21/the-hidden-costs-of-workplace-drug-screening/ 2026-06-15T23:47:34+00:00 https://ibs.inc/wp-content/uploads/2023/11/IFP-Website-Article-Feature-Image-38.png https://ibs.inc/2023/11/20/intelligent-fingerprinting-drug-screening-video/ 2026-06-15T23:47:41+00:00 https://ibs.inc/wp-content/uploads/2023/08/IFP-Video.png https://ibs.inc/2023/11/09/intelligent-bio-solutions-inc-reports-fiscal-2024-first-quarter/ 2026-06-15T23:48:04+00:00 https://ibs.inc/wp-content/uploads/2023/11/Intelligent-Bio-Solutions-Inc.-Reports-Fiscal-2024-First-Quarter-Financial-Results-and-Operational-Highlights.png https://ibs.inc/wp-content/uploads/2023/11/Intelligent-Bio-Solutions-Inc.-Reports-Fiscal-2024-First-Quarter-Financial-Results-and-Operational-Highlights-1.png https://ibs.inc/wp-content/uploads/2023/11/Intelligent-Bio-Solutions-Inc.-Reports-Fiscal-2024-First-Quarter-Financial-Results-and-Operational-Highlights-2.png https://ibs.inc/2023/10/24/intelligent-fingerprinting-drug-screening-solution-now-offered-in-new-zealand/ 2026-06-15T23:48:05+00:00 https://ibs.inc/wp-content/uploads/2023/10/Intelligent-Bio-Solutions-Innovative-Drug-Screening-Technology-Now-Offered-in-New-Zealand.jpg https://ibs.inc/2023/10/05/closing-of-public-offering/ 2026-06-15T23:48:07+00:00 https://ibs.inc/wp-content/uploads/2023/10/IBS-announces-closing-of-public-offering.png https://ibs.inc/2023/10/05/fingerprint-drug-screening-portfolio-grows-and-major-milestone-hit/ 2026-06-15T23:48:07+00:00 https://ibs.inc/wp-content/uploads/2023/10/IFP-Website-Article-Feature-Image-35.png https://ibs.inc/2023/10/03/public-offering/ 2026-06-15T23:48:08+00:00 https://ibs.inc/wp-content/uploads/2023/10/News-and-Media-Intelligent-Bio-Solutions-Inc.-Announces-Pricing-of-4000000-Underwritten-Public-Offering.jpg https://ibs.inc/2023/09/27/intelligent-bio-solutions-obtains-iso-recertification-for-drug-screening-solutio/ 2026-06-15T23:48:09+00:00 https://ibs.inc/wp-content/uploads/2023/09/ISO-Logo.png https://ibs.inc/2023/09/22/workplace-safety-show/ 2026-06-15T23:48:09+00:00 https://ibs.inc/wp-content/uploads/2023/09/IFP-Website-Article-Feature-Image-34.png https://ibs.inc/2023/09/09/intelligent-bio-solutions-plans-to-add-ketamine-and-tramadol-to-drug-screening-solution/ 2026-06-15T23:48:10+00:00 https://ibs.inc/wp-content/uploads/2023/09/IBS-Website-Article-Photo-31.png https://ibs.inc/2023/08/25/intelligent-bio-solutions-inc-reports-fiscal-2023-fourth-quarter-and-full-year-financial-results-and-operational-highlights/ 2026-06-15T23:48:11+00:00 https://ibs.inc/wp-content/uploads/2023/08/Global-Expansion.jpg https://ibs.inc/wp-content/uploads/2023/08/Intelligent-Bio-Solutions-Inc.-Reports-Fiscal-2023-Fourth-Quarter-and-Full-Year-Financial-Results-and-Operational-Highlights-1.png https://ibs.inc/wp-content/uploads/2023/08/Intelligent-Bio-Solutions-Inc.-Reports-Fiscal-2023-Fourth-Quarter-and-Full-Year-Financial-Results-and-Operational-Highlights-2.png https://ibs.inc/2023/07/26/palletways/ 2026-06-15T23:48:12+00:00 https://ibs.inc/wp-content/uploads/2023/07/Palletways.jpg https://ibs.inc/2023/08/02/product-launch-in-australia/ 2026-06-15T23:48:12+00:00 https://ibs.inc/wp-content/uploads/2023/08/sydney-harbour.jpg https://ibs.inc/2023/07/07/tscom/ 2026-06-15T23:48:13+00:00 https://ibs.inc/wp-content/uploads/2023/07/TSCOM-Chile.jpg https://ibs.inc/2023/06/29/regulatory-pathway-guidance-u-s-fda/ 2026-06-15T23:48:14+00:00 https://ibs.inc/wp-content/uploads/2023/06/Regulatory-Pathway-Cartridge.jpg https://ibs.inc/2023/06/21/australian-government-scientific-grant/ 2026-06-15T23:48:14+00:00 https://ibs.inc/wp-content/uploads/2023/06/parliament-house-canberra.jpg https://ibs.inc/2023/05/16/ld-micro-invitational-xiii/ 2026-06-15T23:48:15+00:00 https://ibs.inc/wp-content/uploads/2023/05/Micro-Invitational.jpg https://ibs.inc/2023/05/15/fentanyl-testing/ 2026-06-15T23:48:16+00:00 https://ibs.inc/wp-content/uploads/2023/05/Fentanyl.jpg https://ibs.inc/2023/05/02/intelligent-bio-solutions-scales-reach-throughout-asia-pacific/ 2026-06-15T23:48:17+00:00 https://ibs.inc/wp-content/uploads/2023/04/intelligent-drug-screening-cartridge.png https://ibs.inc/2023/05/12/fiscal-third-quarter-highlights/ 2026-06-15T23:48:17+00:00 https://ibs.inc/wp-content/uploads/2023/05/Financial-Highlights.jpg https://ibs.inc/wp-content/uploads/2023/05/Pages-from-20230511-INBS_GBS-Earnings-release-Q2-2023-FINAL71-823x1024.png https://ibs.inc/wp-content/uploads/2023/05/Pages-from-20230511-INBS_GBS-Earnings-release-Q2-2023-FINAL71-2-1024x1019.png https://ibs.inc/2023/11/03/fingerprint-drug-screening-solution-showcased-at-imarc-2023/ 2026-06-15T23:48:30+00:00 https://ibs.inc/wp-content/uploads/2023/11/IBS-Website-Article-Photo-30.png https://ibs.inc/2023/10/20/the-human-cost-of-drug-use-in-mining/ 2026-06-15T23:48:35+00:00 https://ibs.inc/wp-content/uploads/2023/11/The-Human-Cost-of-Drug-Use-in-Mining.png https://ibs.inc/2023/04/26/uk-food-processing-equipment-manufacturer-latest-to-adopt-intelligent-bio-solutions-portable-fingerprint-drug-testing-solution/ 2026-06-15T23:49:31+00:00 https://ibs.inc/wp-content/uploads/2023/04/Dodman.jpg https://ibs.inc/2023/04/17/inbs-secures-uk-patent-for-intelligent-fingerprinting-reader/ 2026-06-15T23:49:32+00:00 https://ibs.inc/wp-content/uploads/2023/04/intelligent-drug-screening-reader.png https://ibs.inc/2023/03/13/ibs-inc-selects-hasta-laboratory-as-drug-testing-specialist/ 2026-06-15T23:49:33+00:00 https://ibs.inc/wp-content/uploads/2023/03/Back-to-Lab-Testing.png https://ibs.inc/2023/03/10/ibs-inc-announces-closing-of-public-offering/ 2026-06-15T23:49:34+00:00 https://ibs.inc/wp-content/uploads/2023/03/IFP-Website-Article-Feature-Image-39.png https://ibs.inc/2023/03/08/ibs-inc-announces-pricing-of-2-2-million-public-offering/ 2026-06-15T23:49:35+00:00 https://ibs.inc/wp-content/uploads/2023/03/HASTA-Lab-Testing.png https://ibs.inc/2023/03/01/intelligent-bio-solutions-inc-regains-compliance-with-nasdaq-listing-requirement/ 2026-06-15T23:49:36+00:00 https://ibs.inc/wp-content/uploads/2023/03/NASDAQ.png https://ibs.inc/2023/03/07/intelligent-bio-solutions-inc-announces-proposed-public-offering/ 2026-06-15T23:49:36+00:00 https://ibs.inc/wp-content/uploads/2023/03/Public-Offering-IBS-Inc.png https://ibs.inc/2023/02/16/intelligent-bio-solutions-inc-files-fda-513g-submission/ 2026-06-15T23:49:37+00:00 https://ibs.inc/wp-content/uploads/2023/02/regulatory-submission.png https://ibs.inc/2023/02/14/ibs-inc-reports-fiscal-2023-second-quarter-financial-results-and-operational-highlights/ 2026-06-15T23:49:38+00:00 https://ibs.inc/wp-content/uploads/2023/02/Financial-Highlights.png https://ibs.inc/wp-content/uploads/2023/02/Intelligent-Bio-Solutions-Inc.-Reports-Fiscal-2023-Second-1024x769.png https://ibs.inc/wp-content/uploads/2023/02/Reports-Fiscal-2023-Second-986x1024.png https://ibs.inc/2023/01/31/hozelock-to-introduce-intelligent-drug-screening/ 2026-06-15T23:49:39+00:00 https://ibs.inc/wp-content/uploads/2023/01/hozelock.png https://ibs.inc/2023/02/07/boughey-distribution-to-implement-fingerprint-drug-testing/ 2026-06-15T23:49:39+00:00 https://ibs.inc/wp-content/uploads/2023/02/Boughey-Logistics.png https://ibs.inc/2023/01/22/key-milestone-reached-in-biosensor-platform-development/ 2026-06-15T23:49:40+00:00 https://ibs.inc/wp-content/uploads/2023/01/Glucose-Molecule.png https://ibs.inc/2023/01/16/cancellation-of-fy2021-annual-meeting/ 2026-06-15T23:49:41+00:00 https://ibs.inc/wp-content/uploads/2023/01/intelligent-bio-solutions-graphic.png https://ibs.inc/2023/01/16/intelligent-bio-solutions-inc-announces-closing-of-private-placement-offering/ 2026-06-15T23:49:41+00:00 https://ibs.inc/wp-content/uploads/2023/01/biotech-stock-market.png https://ibs.inc/2022/11/10/q1-financial-results-2022/ 2026-06-15T23:49:42+00:00 https://ibs.inc/wp-content/uploads/2022/11/Business.png https://ibs.inc/2022/11/08/goldstar-transport-switching-to-fingerprint-drug-screening-system/ 2026-06-15T23:49:43+00:00 https://ibs.inc/wp-content/uploads/2023/05/Transport-Industry.jpg https://ibs.inc/2022/11/08/eastern-airways-adopts-intelligent-drug-screening-system/ 2026-06-15T23:49:43+00:00 https://ibs.inc/wp-content/uploads/2022/11/white-paper-aeroplane.jpg https://ibs.inc/2022/11/08/gbs-inc-acquires-intelligent-fingerprinting-limited-and-its-proprietary-drugs-of-abuse-screening-technology-2/ 2026-06-15T23:49:44+00:00 https://ibs.inc/wp-content/uploads/2023/09/drug-screening.jpg https://ibs.inc/2022/11/08/gbs-inc-acquires-intelligent-fingerprinting-limited-and-its-proprietary-drugs-of-abuse-screening-technology/ 2026-06-15T23:49:45+00:00 https://ibs.inc/wp-content/uploads/2022/11/intelligent-bio-solutions-acquires-intelligent-fingerprinting.png https://ibs.inc/2023/03/27/a-f-sprinklers-selects-intelligent-bio-solutions-latest-dsr-plus-screening-unit-to-support-its-random-drug-screening-program/ 2026-06-15T23:49:52+00:00 https://ibs.inc/wp-content/uploads/2023/03/IFP-Website-Article-Feature-Image-37.png https://ibs.inc/2022/05/10/gbs-inc-reports-third-quarter-2022-financial-results-andrecent-business-highlights/ 2026-06-15T23:50:54+00:00 https://ibs.inc/wp-content/uploads/2022/05/science-laboratory.jpg https://ibs.inc/wp-content/uploads/2022/05/third-quarter-financial-results-2022-2.png https://ibs.inc/wp-content/uploads/2022/05/third-quarter-financial-results-2022-1-949x1024.png https://ibs.inc/2021/08/11/gbs-inc-reports-fourth-quarter-and-full-year-2021-preliminary-financial-results-and-recent-business-highlights/ 2026-06-15T23:50:55+00:00 https://ibs.inc/wp-content/uploads/2021/08/Business-Highlights.jpg https://ibs.inc/2021/11/11/gbs-inc-reports-first-quarter-2022-financial-results-and-recent-business-highlights/ 2026-06-15T23:50:55+00:00 https://ibs.inc/wp-content/uploads/2022/06/The-Saliva-Glucose-Biosensor-Banner-3.png https://ibs.inc/2021/05/16/gbs-inc-reports-first-quarter-2021-financial-results-and-recent-business-highlights/ 2026-06-15T23:50:56+00:00 https://ibs.inc/wp-content/uploads/2021/05/First-Quarter-Business-Results.jpg https://ibs.inc/2026/07/21/intelligent-bio-solutions-completes-precision-testing/ 2026-07-21T12:30:33+00:00 https://ibs.inc/wp-content/uploads/2026/07/Intelligent-Bio-Solutions-Completes-Precision-Testing-Strengthening-FDA-510k-Submission-Package-Ahead-of-Planned-Entry-into-Multi-Billion-Dollar-U.S.-Drug-Screening-Market.png https://ibs.inc/2026/07/23/inbs-achieves-key-milestone-ahead-of-fda-510k-submission/ 2026-07-23T12:30:36+00:00 https://ibs.inc/wp-content/uploads/2026/07/INBS-Achieves-Key-Milestone-Ahead-of-FDA-510k-Submission.png https://ibs.inc/2026/07/24/what-intelligent-bio-solutions-does-and-the-problem-it-solves/ 2026-07-24T04:05:59+00:00 https://ibs.inc/wp-content/uploads/2026/07/IBS-Website-Article-Feature-Image-9.png https://ibs.inc/2026/08/03/inbs-completes-interference-study/ 2026-08-03T12:30:06+00:00 https://ibs.inc/wp-content/uploads/2026/08/Intelligent-Bio-Solutions-Completes-Interference-Study-Examining-the-Impact-of-Everyday-Substances-on-Intelligent-Fingerprinting-System.png https://ibs.inc/2026/08/05/inbs-completes-usability-study-supporting-fda-submission/ 2026-08-09T23:42:58+00:00 https://ibs.inc/wp-content/uploads/2026/08/Intelligent-Bio-Solutions-Completes-Usability-Study-Supporting-FDA-510k-Submission.png https://ibs.inc/2026/08/11/inbs-announces-completion-of-method-comparison-study/ 2026-08-11T12:30:27+00:00 https://ibs.inc/wp-content/uploads/2026/08/INBS-Announces-Completion-of-Method-Comparison-Study-for-the-Intelligent-Fingerprinting-Drug-Screening-System-.png https://ibs.inc/2026/08/17/inbs-strengthens-quality-management-with-iso-recertification/ 2026-08-17T12:30:13+00:00 https://ibs.inc/wp-content/uploads/2026/08/Intelligent-Bio-Solutions-Strengthens-Quality-Management-Credentials-with-ISO-Recertification-.png https://ibs.inc/2026/08/19/inbs-reports-fiscal-2026-full-year-revenue-growth/ 2026-08-19T12:30:42+00:00 https://ibs.inc/wp-content/uploads/2026/08/INBS-Reports-Fiscal-2026-Full-Year-Revenue-Growth-of-38-YoY.png https://ibs.inc/wp-content/uploads/2026/08/FINAL_Fiscal-2026-Earnings-PR-08.19.26_Page_4-scaled-e1787096116517.png https://ibs.inc/wp-content/uploads/2026/08/FINAL_Fiscal-2026-Earnings-PR-08.19.26_Page_5-scaled-e1787096147111.png